HLDF-6 peptides exhibit neuroprotective effects in the experimental model of preclinical Parkinson's disease.

Abstract

The mechanisms of the neuroprotective action of the hexapeptides HLDF-6 encoded by the amino acid sequence 41-46 of Human Leukemia Differentiation Factor and its homoserine derivative HLDF-6H were studied in an experimental 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced model of Parkinson's disease (PD). C57Bl/6 mice received two intraperitoneal injections of 18 mg/kg MPTP-HCl, with an interval of 2 hours. MPTP-induced motor dysfunction was assessed using horizontal grid test. Our data show that chronic intranasal administration of peptides (3 weeks, 300 μg/kg/day) restored normal levels of dopamine and improved its turnover rates in the striatum. Furthermore, peptide administration increased serum estradiol levels and led to a significant improvement in motor functions in MPTP-treated mice. Additionally, peptide treatment increased the levels of mRNA encoding neurotrophin BDNF, but normalized the levels of mRNA encoding the inflammatory mediators TGFβ1, IL1β and IFNγ in the brain. Collectively, our behavioral and biochemical studies demonstrate that HLDF-6 peptides have a therapeutic potential for treating PD. We propose that HLDF-6 peptides may exert their neuroprotective mechanism, at least in part, by normalizing estradiol levels and modulating the expression of key factors involved in neurotrophic support and neuroinflammation.

• Authors: Yurii A Zolotarev, Stanislav I Shram, Aleksandr K Dadayan, Oleg V Dolotov, Dmitriy D Markov, Igor Yu Nagaev, Vladimir S Kudrin, Viktor B Narkevich, Oleg Yu Sokolov, Natalya V Kost
• Journal: Neuropeptides (Neuropeptides) Vol. 96 Pg. 102287 (Dec 2022) ISSN: 1532-2785 [Electronic] Netherlands
• PMID: 36280440 (Publication Type: Journal Article)
• Copyright: Copyright © 2022. Published by Elsevier Ltd.

Chemical References

• Neuroprotective Agents
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
• threonyl-glycyl-glutamyl-asparaginyl-histidylarginine
• Peptides
• Estradiol
• RNA, Messenger

Topics

• Mice
• Animals
• Humans
• Neuroprotective Agents (pharmacology, therapeutic use)
• Parkinson Disease (drug therapy)
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (therapeutic use)
• Mice, Inbred C57BL
• Peptides (pharmacology, therapeutic use)
• Estradiol
• Models, Theoretical
• RNA, Messenger
• Disease Models, Animal